Clonality testing of lymphoproliferative disorders in a large cohort of primary and consultant biopsies

Biomed Pap Med Fac Univ Palacky Olomouc Czech Repub. 2017 Jun;161(2):197-205. doi: 10.5507/bp.2017.006. Epub 2017 Mar 14.

Abstract

Background: Lymphoproliferative disease often presents the clinician and pathologist with a diagnostic dilemma, particularly in the early course of the disease.

Methods: We used modified BIOMED-2 protocols to detect monoclonal expansions of immunoglobulin heavy chain (IgH) and T-cell receptor (TCR) genes in 957 formalin-fixed paraffin-embedded samples from 717 patients. To eliminate false-positive results, heteroduplex analysis was used after PCR reactions. The impact of different fixatives on DNA quality and performance of PCR was assessed.

Results: In the class of B lymphomas we detected clonal IgH rearrangement in nearly 80% of cases and in the class of T lymphomas in 64% of cases. Performance of the assays was 94.7% and 92.5% for IgH and TCR clonality, respectively. Clonality rates in various B and T lymphomas were in concordance with previous studies. We also present 10 difficult cases where PCR analysis of IgH and TCR gene rearrangements significantly contributed to a decision on the correct diagnosis.

Conclusion: These results confirm that the PCR-based analysis is suitable as a routine method and is helpful in establishing a diagnosis in morphologically unclear cases.

Keywords: clonality; IgH and TCR gene rearrangement; lymphoid proliferation; polymerase chain reaction; BIOMED-2.

Publication types

  • Case Reports

MeSH terms

  • Adult
  • Aged
  • Biopsy
  • Clone Cells
  • Cohort Studies
  • Female
  • Gene Rearrangement*
  • Humans
  • Immunoglobulin G / genetics*
  • Lymphoproliferative Disorders / diagnostic imaging*
  • Lymphoproliferative Disorders / genetics*
  • Male
  • Middle Aged
  • Receptors, Antigen, T-Cell / genetics*
  • Young Adult

Substances

  • Immunoglobulin G
  • Receptors, Antigen, T-Cell